|
DENND5A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.05480000184488E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.88660000002938E-06 |
| Normal-vs-Stage2 |
1.819380E-04 |
| Normal-vs-Stage3 |
2.34809999999364E-07 |
| Normal-vs-Stage4 |
6.39230002263957E-09 |
| Stage1-vs-Stage2 |
6.089200E-01 |
| Stage1-vs-Stage3 |
7.578400E-02 |
| Stage1-vs-Stage4 |
6.335400E-03 |
| Stage2-vs-Stage3 |
4.758200E-01 |
| Stage2-vs-Stage4 |
7.849800E-02 |
| Stage3-vs-Stage4 |
2.264000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.02339999492096E-08 |
| Normal-vs-AfricanAmerican |
2.416900E-03 |
| Normal-vs-Asian |
5.626700E-04 |
| Caucasian-vs-AfricanAmerican |
8.118400E-01 |
| Caucasian-vs-Asian |
7.476200E-01 |
| AfricanAmerican-vs-Asian |
9.948000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78049999999264E-06 |
| Normal-vs-Female |
4.26740000003534E-08 |
| Male-vs-Female |
7.203400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.401560E-04 |
| Normal-vs-Age(41-60Yrs) |
3.18449999703319E-08 |
| Normal-vs-Age(61-80Yrs) |
9.56360002302148E-09 |
| Normal-vs-Age(81-100Yrs) |
6.311900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.276500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.200800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.329600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.007600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.094000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.276800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.350000E-02 |
| Classical-VS-Follicular |
1.361610E-01 |
| Classical-VS-Other |
1.785050E-01 |
| Classical-VS-Normal |
1.8907000000068E-06 |
| Tall-VS-Follicular |
5.290800E-01 |
| Tall-VS-Other |
6.511000E-01 |
| Tall-VS-Normal |
1.77019999999528E-05 |
| Follicular-VS-Other |
4.595800E-01 |
| Follicular-VS-Normal |
2.91870000002081E-06 |
| Other-VS-Normal |
4.176800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.10689999949432E-07 |
| Normal-vs-N1 |
3.45030000015178E-07 |
| N0-vs-N1 |
2.008000E-01 |
|
|
